Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease
Enterprise Therapeutics is a leading pharmaceutical manufacturing company dedicated to the discovery and development of innovative therapies aimed at improving the lives of patients suffering from respiratory diseases. With a focus on addressing the underlying mechanisms of mucus congestion in conditions such as cystic fibrosis, asthma, and COPD, Enterprise Therapeutics strives to reduce the frequency of lung infections and enhance patient quality of life.
Operating from its primary address at University of Sussex, Science Park Square, Brighton, East Sussex BN1 9SB, GB, Enterprise Therapeutics leverages significant expertise in drug discovery, drug development, respiratory biology, and ion channel pharmacology. The company is committed to advancing medicinal chemistry and epithelial cell biology to create impactful treatments.
Enterprise Therapeutics is poised for continued growth and success in the pharmaceutical sector. We invite the management team at Enterprise Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further expand your reach and commercial opportunities.
Enterprise Therapeutics est une entreprise pharmaceutique de premier plan dédiée à la découverte et au développement de thérapies innovantes visant à améliorer la vie des patients souffrant de maladies respiratoires. En se concentrant sur les mécanismes sous-jacents de la congestion du mucus dans des affections telles que la mucoviscidose, l'asthme et la BPCO, Enterprise Therapeutics s'efforce de réduire la fréquence des infections pulmonaires et d'améliorer la qualité de vie des patients.
Opérant depuis son adresse principale à University of Sussex, Science Park Square, Brighton, East Sussex BN1 9SB, GB, Enterprise Therapeutics tire parti d'une expertise significative dans la découverte de médicaments, le développement de médicaments, la biologie respiratoire et la pharmacologie des canaux ioniques. L'entreprise s'engage à faire progresser la chimie médicinale et la biologie des cellules épithéliales afin de créer des traitements efficaces.
Enterprise Therapeutics est prête pour une croissance et un succès continus dans le secteur pharmaceutique. Nous invitons l'équipe de direction d'Enterprise Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'étendre davantage votre portée et vos opportunités commerciales.
Compare Enterprise Therapeutics with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Enterprise TherapeuticsMain Company |
EspeRare foundationView Profile |
CQDMView Profile |
JC DiscoveryView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2013 | 2008 | 2022 |
|
Company Size
|
— | 2-10 | 11-50 | 2-10 |
|
City
|
Brighton, East Sussex | Genève, Genève | Montreal, Quebec | |
|
Country
|
United Kingdom | Switzerland | Canada | |
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Pharmaceutical Manufacturing
Drug Discovery
Respiratory Diseases
Cystic Fibrosis
Asthma
COPD
Ion Channel Pharmacology
Medicinal chemistry
Drug development
Epithelial cell biology
Ion channel pharmacology
Cystic fibrosis
Drug discovery
|
10 Total
10 Unique
Unique Skills:
Biotechnology
data science
drug repositioning
Genetic diseases
Genetics
Patient centered
+4
|
18 Total
18 Unique
Unique Skills:
Biopharmaceutical R&D
Biopharmaceutical research
Biotechnology research
Collaborative research
Financement
Funding
+12
|
26 Total
26 Unique
Unique Skills:
Bispecific antibodies
BSL3
CAR-NK cells
CAR-T cells
Challenge testing
CIPHE
+20
|
Other organizations in the same industry
This company is also known as